Clinical Trial Update: A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS) [Phase 2]

View source ↗

Summary

A Phase 2 trial of RG1662 in adults and adolescents with Down syndrome (CLEMATIS) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome

Drugs mentioned

• RG1662

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Down Syndrome | Phase 2 | Status: COMPLETED